Sample: Between 2013 and 2016, what percentage, overall, of US adults tried to lose weight in the past 12 months?
Lenacapavir Approved for Twice-Yearly Injection for HIV Prevention, a Landmark FDA Decision
The only pre-exposure prophylaxis approved for twice-a-year dosing, lenacapavir "could be the transformative PrEP option we’ve been waiting for," one expert said.
The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment
Clinical insights on cannabis and dementia, hormonal contraceptives and postpartum depression, the FDA-approved blood test for Alzheimer disease, more.
FDA Clears Happy Ring for At-Home Diagnosis of Sleep Apnea and Insomnia
The FDA cleared Happy Ring, a wearable device for at-home diagnosis of sleep disorders, enhancing access to vital sleep health solutions.
The Weekly Dose: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship
Discover the latest breakthroughs in clinical research, from at-home cancer screening to AI advancements in mammography, shaping future healthcare practices.
Coexisting HTN, T2D in US Adults Doubled Over 2 Decades: Daily Dose
Your daily dose of the clinical news you may have missed.
Atogepant Superior to Topiramate for Migraine Prevention in Phase 3 Head-to-Head TEMPLE Study
The superior tolerability and efficacy of the CGRP-targeting atogepant supports recent calls from the AHS to consider the class as first-line preventive therapy for migraine.